These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Interaction between cytochrome P-450scc and adrenodoxin in solution under effects of low spin effectors]. Radiuk VG; Shkumatov VM; Chashchin VL; Akhrema AA Biokhimiia; 1982 Oct; 47(10):1700-9. PubMed ID: 7171649 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of protein-protein interactions in an enzymatically complete cholesterol hydroxylating system]. Radiuk VG; Shkumatov VM; Chashchin VL; Akhrem AA Biokhimiia; 1982 Nov; 47(11):1792-801. PubMed ID: 7150671 [TBL] [Abstract][Full Text] [Related]
4. Effects of cholesterol and adrenodoxin binding on the heme moiety of cytochrome P-450scc: a resonance Raman study. Tsubaki M; Hiwatashi A; Ichikawa Y Biochemistry; 1986 Jun; 25(12):3563-9. PubMed ID: 3718944 [TBL] [Abstract][Full Text] [Related]
5. Effects of phospholipid and detergent on the substrate specificity of adrenal cytochrome P-450scc. Substrate binding and kinetics of cholesterol side chain oxidation. Greenfield NJ; Gerolimatos B; Szwergold BS; Wolfson AJ; Prasad VV; Lieberman S J Biol Chem; 1981 May; 256(9):4407-17. PubMed ID: 6260797 [TBL] [Abstract][Full Text] [Related]
6. The formation of binary and ternary complexes of cytochrome P-450scc with adrenodoxin and adrenodoxin reductase.adrenodoxin complex. The implication in ACTH function. Kido T; Kimura T J Biol Chem; 1979 Dec; 254(23):11806-15. PubMed ID: 227881 [TBL] [Abstract][Full Text] [Related]
7. The catalytic cycle of cytochrome P-450scc and intermediates in the conversion of cholesterol to pregnenolone. Hume R; Kelly RW; Taylor PL; Boyd GS Eur J Biochem; 1984 May; 140(3):583-91. PubMed ID: 6723652 [TBL] [Abstract][Full Text] [Related]
8. Participation of the membrane in the side chain cleavage of cholesterol. Reconstitution of cytochrome P-450scc into phospholipid vesicles. Seybert DW; Lancaster JR; Lambeth JD; Kamin H J Biol Chem; 1979 Dec; 254(23):12088-98. PubMed ID: 500697 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of electron transfer from adrenodoxin to cytochrome P-450scc by chemical modification with pyridoxal 5'-phosphate: identification of adrenodoxin-binding site of cytochrome P-450scc. Tsubaki M; Iwamoto Y; Hiwatashi A; Ichikawa Y Biochemistry; 1989 Aug; 28(17):6899-907. PubMed ID: 2819041 [TBL] [Abstract][Full Text] [Related]
10. Cytochrome P-450 of adrenal mitochondria. Spin states as detected by difference spectroscopy. Jefcoate CR J Biol Chem; 1975 Jun; 250(12):4663-70. PubMed ID: 167000 [TBL] [Abstract][Full Text] [Related]
11. Cytochrome P-450scc-phospholipid interactions. Evidence for a cardiolipin binding site and thermodynamics of enzyme interactions with cardiolipin, cholesterol, and adrenodoxin. Pember SO; Powell GL; Lambeth JD J Biol Chem; 1983 Mar; 258(5):3198-206. PubMed ID: 6826558 [No Abstract] [Full Text] [Related]
12. Electron transfer to cytochrome P-450scc limits cholesterol-side-chain-cleavage activity in the human placenta. Tuckey RC; Woods ST; Tajbakhsh M Eur J Biochem; 1997 Mar; 244(3):835-9. PubMed ID: 9108254 [TBL] [Abstract][Full Text] [Related]
13. Cross-linking studies of the cholesterol hydroxylation system from bovine adrenocortical mitochondria. Turko IV; Adamovich TB; Kirillova NM; Usanov SA; Chashchin VL Biochim Biophys Acta; 1989 Jun; 996(1-2):37-42. PubMed ID: 2736257 [TBL] [Abstract][Full Text] [Related]
14. Temperature dependence of cholesterol binding to cytochrome P-450scc of the rat adrenal. Effect of adrenocorticotropic hormone and cycloheximide. Paul DP; Gallant S; Orme-Johnson NR; Orme-Johnson WH; Brownie AC J Biol Chem; 1976 Nov; 251(22):7120-6. PubMed ID: 11217 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome P-450 of bovine adrenal mitochondria. Ligand binding to two forms resolved by EPR spectroscopy. Jefcoate CR; Orme-Johnson WH; Beinhert H J Biol Chem; 1976 Jun; 251(12):3706-15. PubMed ID: 6460 [TBL] [Abstract][Full Text] [Related]
16. Cytochrome P-450scc induces vesicle aggregation through a secondary interaction at the adrenodoxin binding sites (in competition with protein exchange. Dhariwal MS; Kowluru RA; Jefcoate CR Biochemistry; 1991 May; 30(20):4940-9. PubMed ID: 2036362 [TBL] [Abstract][Full Text] [Related]
17. [Effect of chemical modification of tyrosine residues of cholesterol-hydroxylating cytochrome P-450 on the interaction with high-spin effectors]. Chashchin VL; Pikuleva IA; Akhrem AA; Usanov SA Biokhimiia; 1985 Jan; 50(1):128-38. PubMed ID: 3978151 [TBL] [Abstract][Full Text] [Related]
18. The side-chain cleavage of cholesterol sulfate--I. The effect of adrenodoxin on the binding of cholesterol sulfate to cytochrome P-450scc. Greenfield NJ; Gerolimatos B J Steroid Biochem; 1985 Jun; 22(6):809-16. PubMed ID: 4021484 [TBL] [Abstract][Full Text] [Related]
19. Adrenodoxin with a COOH-terminal deletion (des 116-128) exhibits enhanced activity. Cupp JR; Vickery LE J Biol Chem; 1989 Jan; 264(3):1602-7. PubMed ID: 2912975 [TBL] [Abstract][Full Text] [Related]
20. Interaction of a spin-labelled cholesterol derivative with the cytochrome P-450scc active site. Lange R; Maurin L; Larroque C; Bienvenüe A Eur J Biochem; 1988 Feb; 172(1):189-95. PubMed ID: 3345759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]